Published in Dev Biol on October 01, 1988
B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regul (1989) 2.40
Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J Cell Biol (1990) 2.33
Induced expression of syndecan in healing wounds. J Cell Biol (1991) 1.67
Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. Mol Biol Cell (1995) 1.40
Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells. Proc Natl Acad Sci U S A (1992) 1.29
Syndecan and tenascin expression is induced by epithelial-mesenchymal interactions in embryonic tooth mesenchyme. J Cell Biol (1989) 1.19
Stage-specific expression patterns of alkaline phosphatase during development of the first arch skeleton in inbred C57BL/6 mouse embryos. J Anat (1997) 1.17
Syndecan-1 mediates cell spreading in transfected human lymphoblastoid (Raji) cells. J Cell Biol (1996) 1.15
Transforming growth factor (type beta) promotes the addition of chondroitin sulfate chains to the cell surface proteoglycan (syndecan) of mouse mammary epithelia. J Cell Biol (1989) 1.14
Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck. Br J Cancer (1994) 1.12
Cellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction. Endocr Rev (2008) 1.10
Trans-repressor activity of nuclear glycosaminoglycans on Fos and Jun/AP-1 oncoprotein-mediated transcription. J Cell Biol (1992) 1.06
Midkine (MK), a heparin-binding growth/differentiation factor, is regulated by retinoic acid and epithelial-mesenchymal interactions in the developing mouse tooth, and affects cell proliferation and morphogenesis. J Cell Biol (1995) 1.06
Syndecan-1 expression has prognostic significance in head and neck carcinoma. Br J Cancer (1999) 1.03
Steroid-induced epithelial-fibroblastic conversion associated with syndecan suppression in S115 mouse mammary tumor cells. Cell Regul (1991) 0.98
Origin and deposition of basement membrane heparan sulfate proteoglycan in the developing intestine. J Cell Biol (1989) 0.94
Characterization of glycosaminoglycans by 15N NMR spectroscopy and in vivo isotopic labeling. Anal Chem (2010) 0.91
Immunohistochemical localization of syndecan in mouse skin tumors induced by UV irradiation. Loss of expression associated with malignant transformation. Am J Pathol (1991) 0.91
FGF signaling sustains the odontogenic fate of dental mesenchyme by suppressing β-catenin signaling. Development (2013) 0.89
Activation of an enhancer on the syndecan-1 gene is restricted to fibroblast growth factor family members in mesenchymal cells. Mol Cell Biol (1997) 0.87
Exploiting enzyme specificities in digestions of chondroitin sulfates A and C: production of well-defined hexasaccharides. Glycobiology (2012) 0.82
Inactivation of Fam20B in the dental epithelium of mice leads to supernumerary incisors. Eur J Oral Sci (2015) 0.79
Effects of Detergent-Based Protocols on Decellularization of Corneas With Sclerocorneal Limbus. Evaluation of Regional Differences. Transl Vis Sci Technol (2015) 0.78
Syndecan expressions in the human amnion and chorionic plate. Eur J Histochem (2010) 0.78
Translational suppression of syndecan-1 expression in Ha-ras transformed mouse mammary epithelial cells. Mol Biol Cell (1993) 0.78
Daughters of the Enamel Organ: Development, Fate, and Function of the Stratum Intermedium, Stellate Reticulum, and Outer Enamel Epithelium. Stem Cells Dev (2016) 0.75
Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature (1994) 6.57
RNA codewords and protein synthesis, VII. On the general nature of the RNA code. Proc Natl Acad Sci U S A (1965) 5.17
Specificities of heparan sulphate proteoglycans in developmental processes. Nature (2000) 3.46
The differential effect of prenatal care on the incidence of low birth weight among blacks and whites in a prepaid health care plan. N Engl J Med (1988) 3.20
Wnt-4 is a mesenchymal signal for epithelial transformation of metanephric mesenchyme in the developing kidney. Development (1998) 2.90
Molecular cloning of syndecan, an integral membrane proteoglycan. J Cell Biol (1989) 2.88
RNA codewords and protein synthesis, 8. Nucleotide sequences of synonym codons for arginine, valine, cysteine, and alanine. Proc Natl Acad Sci U S A (1965) 2.86
Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol (1992) 2.52
B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regul (1989) 2.40
Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J Immunol (1988) 2.39
Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J Biol Chem (1997) 2.38
Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J Cell Biol (2000) 2.33
Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor for interstitial matrix. J Cell Biol (1988) 2.26
Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice. Nat Genet (2000) 2.23
Cell surface proteoglycan associates with the cytoskeleton at the basolateral cell surface of mouse mammary epithelial cells. J Cell Biol (1986) 2.16
Cell surface proteoglycan of mammary epithelial cells. Protease releases a heparan sulfate-rich ectodomain from a putative membrane-anchored domain. J Biol Chem (1985) 2.13
Immunocytochemistry of cell surface heparan sulfate proteoglycan in mouse tissues. A light and electron microscopic study. J Histochem Cytochem (1987) 2.07
Psychological performance of subjects with low exposure to lead. J Occup Med (1978) 2.05
Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc Natl Acad Sci U S A (1994) 2.02
Cell surface heparan sulfate proteoglycans: selective regulators of ligand-receptor encounters. J Biol Chem (2000) 2.01
Regulation of organogenesis. Common molecular mechanisms regulating the development of teeth and other organs. Int J Dev Biol (1995) 2.01
Proteoglycans are required for maintenance of Wnt-11 expression in the ureter tips. Development (1996) 1.99
Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns. Mol Biol Cell (1994) 1.97
Heparan sulfate proteoglycans from mouse mammary epithelial cells. Cell surface proteoglycan as a receptor for interstitial collagens. J Biol Chem (1985) 1.97
Associations of FGF-3 and FGF-10 with signaling networks regulating tooth morphogenesis. Dev Dyn (2000) 1.93
Heparan sulfate proteoglycans from mouse mammary epithelial cells. A putative membrane proteoglycan associates quantitatively with lipid vesicles. J Biol Chem (1983) 1.92
Heparan sulfate proteoglycans from mouse mammary epithelial cells: localization on the cell surface with a monoclonal antibody. J Cell Biol (1985) 1.88
Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2. Nat Med (1998) 1.76
The cell surface proteoglycan from mouse mammary epithelial cells bears chondroitin sulfate and heparan sulfate glycosaminoglycans. J Biol Chem (1985) 1.71
Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation. J Biol Chem (1997) 1.70
Induced expression of syndecan in healing wounds. J Cell Biol (1991) 1.67
Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence. Nature (2001) 1.66
Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization. Blood (1992) 1.65
Wnt signaling is required for thymocyte development and activates Tcf-1 mediated transcription. Eur J Immunol (2001) 1.63
Sequence of human syndecan indicates a novel gene family of integral membrane proteoglycans. J Biol Chem (1990) 1.60
Endothelial heparan sulfate proteoglycan. I. Inhibitory effects on smooth muscle cell proliferation. Am J Respir Cell Mol Biol (1990) 1.60
Molecular polymorphism of a cell surface proteoglycan: distinct structures on simple and stratified epithelia. Proc Natl Acad Sci U S A (1988) 1.57
Kidney morphogenesis: cellular and molecular regulation. Mech Dev (2000) 1.55
Drosophila syndecan: conservation of a cell-surface heparan sulfate proteoglycan. Proc Natl Acad Sci U S A (1994) 1.45
Cell surface proteoglycan of mouse mammary epithelial cells is shed by cleavage of its matrix-binding ectodomain from its membrane-associated domain. J Cell Biol (1987) 1.45
Expression of proteoglycans and hyaluronan during wound healing. J Histochem Cytochem (1995) 1.42
A revived opportunity for fetal research. Nature (1993) 1.40
Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3. Cell (2001) 1.40
Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. Mol Biol Cell (1995) 1.40
Type I collagen reduces the degradation of basal lamina proteoglycan by mammary epithelial cells. J Cell Biol (1981) 1.38
Syndecan from embryonic tooth mesenchyme binds tenascin. J Biol Chem (1991) 1.37
Epithelial-mesenchymal interactions are required for msx 1 and msx 2 gene expression in the developing murine molar tooth. Development (1993) 1.35
Core protein structure and sequence determine the site and presence of heparan sulfate and chondroitin sulfate on syndecan-1. J Biol Chem (1994) 1.34
Remodelling of the basement membrane: morphogenesis and maturation. Ciba Found Symp (1984) 1.33
Heparan sulfate proteoglycans from mouse mammary epithelial cells. Basal extracellular proteoglycan binds specifically to native type I collagen fibrils. J Biol Chem (1984) 1.32
Syndecans-1 and -4 are induced during wound repair of neonatal but not fetal skin. J Invest Dermatol (1996) 1.32
Syndecans, heparan sulfate proteoglycans, maintain the proteolytic balance of acute wound fluids. J Biol Chem (1998) 1.32
Expression of Sprouty genes 1, 2 and 4 during mouse organogenesis. Mech Dev (2001) 1.31
Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal interactions during fetal development and organogenesis. Development (1995) 1.30
Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells. Proc Natl Acad Sci U S A (1992) 1.29
Induction of ureter branching as a response to Wnt-2b signaling during early kidney organogenesis. Dev Dyn (2001) 1.26
Epithelial-mesenchymal interactions regulate the stage-specific expression of a cell surface proteoglycan, syndecan, in the developing kidney. Dev Biol (1989) 1.23
Syndecan-1, a cell-surface proteoglycan, changes in size and abundance when keratinocytes stratify. J Invest Dermatol (1992) 1.22
Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential. Int J Cancer (1997) 1.22
Cellular functions of proteoglycans--an overview. Semin Cell Dev Biol (2001) 1.21
Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains. J Biol Chem (1994) 1.21
Syndecan and tenascin expression is induced by epithelial-mesenchymal interactions in embryonic tooth mesenchyme. J Cell Biol (1989) 1.19
Induced repatterning of type XVIII collagen expression in ureter bud from kidney to lung type: association with sonic hedgehog and ectopic surfactant protein C. Development (2001) 1.18
Binding of human syndecan to extracellular matrix proteins. J Biol Chem (1990) 1.17
Biosynthesis of heparin/heparan sulfate. cDNA cloning and expression of D-glucuronyl C5-epimerase from bovine lung. J Biol Chem (1997) 1.16
Function of the syndecans--a family of cell surface proteoglycans. J Cell Sci (1994) 1.16
Transient expression of a cell surface heparan sulfate proteoglycan (syndecan) during limb development. Dev Biol (1990) 1.13
Neurite growth-promoting protein (amphoterin, p30) binds syndecan. Exp Cell Res (1992) 1.13
Changes in the distribution of tenascin during tooth development. Development (1987) 1.13
The turnover of basal lamina glycosaminoglycan correlates with epithelial morphogenesis. Dev Biol (1982) 1.12
Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck. Br J Cancer (1994) 1.12
Syndecan-1 shedding is enhanced by LasA, a secreted virulence factor of Pseudomonas aeruginosa. J Biol Chem (2000) 1.12
Characterization of the D-glucuronyl C5-epimerase involved in the biosynthesis of heparin and heparan sulfate. J Biol Chem (2001) 1.10
Selective distributions of proteoglycans and their ligands in pericellular matrix of cultured fibroblasts. Implications for their roles in cell-substratum adhesion. J Cell Sci (1993) 1.08
Defective basal lamina formation by transformed mammary epithelial cells: a reduced effect of collagen on basal lamina (heparan sulfate-rich) proteoglycan degradation. J Cell Physiol (1982) 1.07
Growth factors induce 3T3 cells to express bFGF-binding syndecan. J Biol Chem (1992) 1.07
Syndecan-4 is expressed by B lineage lymphocytes and can transmit a signal for formation of dendritic processes. J Immunol (1999) 1.06
Mouse mammary epithelial cells produce basement membrane and cell surface heparan sulfate proteoglycans containing distinct core proteins. J Cell Biol (1988) 1.05
Syndecan-1 expression has prognostic significance in head and neck carcinoma. Br J Cancer (1999) 1.03
Developmental expression of syndecan, an integral membrane proteoglycan, correlates with cell differentiation. Development (1991) 1.03
Basal lamina formation by normal and transformed mouse mammary epithelial cells duplicated in vitro. J Natl Cancer Inst (1981) 1.02
Localization of 17beta-hydroxysteroid dehydrogenase/17-ketosteroid reductase isoform expression in the developing mouse testis--androstenedione is the major androgen secreted by fetal/neonatal leydig cells. Endocrinology (2000) 1.02
Transient expression of syndecan in mesenchymal cell aggregates of the embryonic kidney. Dev Biol (1992) 1.02
Associations between transforming growth factor beta 1 RNA expression and epithelial-mesenchymal interactions during tooth morphogenesis. Development (1991) 1.02
Molecular embryology of the lung: then, now, and in the future. Am J Physiol (1999) 1.02
Analysis of transport and targeting of syndecan-1: effect of cytoplasmic tail deletions. Mol Biol Cell (1994) 1.01
Multifactorial inheritance of neural tube defects: localization of the major gene and recognition of modifiers in ct mutant mice. Nat Genet (1994) 1.01
Simultaneous loss of expression of syndecan-1 and E-cadherin in the embryonic palate during epithelial-mesenchymal transformation. Int J Dev Biol (1998) 1.00
Suppression of tumor cell growth by syndecan-1 ectodomain. J Biol Chem (1994) 0.99
Syndecan-1: a new prognostic marker in laryngeal cancer. Acta Otolaryngol (1997) 0.98